middle.news
Proteomics International Taps David Morris to Accelerate Promarker® Growth
8:52am on Wednesday 14th of January, 2026 AEDT
•
Healthcare
Read Story
Proteomics International Taps David Morris to Accelerate Promarker® Growth
8:52am on Wednesday 14th of January, 2026 AEDT
Key Points
David Morris appointed CEO and Managing Director effective 19 January 2026
Focus on commercialising Promarker® diagnostic pipeline
Founder Dr Richard Lipscombe to retire on 23 February 2026 after 25 years
Morris brings global medical technology and commercial growth expertise
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE